Codman CerebroFlo EVD Catheter Recall Issued by Integra LifeSciences
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Integra LifeSciences Corp. is recalling Codman CerebroFlo EVD Catheter with Endexo Technology due to an out-of-specification endotoxin result.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on June 3, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, medical-device.
What Happened
Integra LifeSciences Corp. (NeuroSciences) initiated a voluntary recall of the Codman CerebroFlo EVD Catheter with Endexo Technology after an out-of-specification endotoxin result that did not meet acceptance criteria.
Which Products Are Affected
The recall affects Codman CerebroFlo EVD Catheter with Endexo Technology, Product ID: 37.550.501, UDI-DI: 10381780530138, Lot Number: 45322. A total of 40 packs (200 units) were distributed nationwide in the United States to the states of Arizona (AZ), Arkansas (AR), California (CA), Connecticut (CT), Florida (FL), Kentucky (KY), Louisiana (LA), Michigan (MI), Minnesota (MN), Missouri (MO), North Carolina (NC), North Dakota (ND), Oklahoma (OK), Oregon (OR), Texas (TX), and Washington (WA). The recall number is Z-2173-2026 and it is classified as Class II.
What You Should Do
No specific consumer action steps are provided in the recall notice.
Why This Matters
The recall involves a device used for diverting cerebrospinal fluid from the ventricles of the brain, affecting 200 units distributed across multiple states.
Source
FDA recall Z-2173-2026: https://www.fda.gov
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,155 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to June 3, 2026.
Frequently Asked Questions
Common questions about this FDA recall.